Glycemic Variability Within 1 Year Following Surgery for Stage II-III Colon Cancer.

Natalie Rasmussen MandolfoAnn M BergerLeeza StruweKathleen M HannaWhitney GoldnerKelsey KluteSean LangenfeldMarilyn Hammer

Published in: Biological research for nursing (2021)

Patients with stage II-III colon cancer with T2D experienced higher glycemic variability within 1 month and within 1 year following surgery compared to those without T2D. Associations between glycemic variability and demographic and clinical characteristics differed by T2D status. Further research in prospective studies is warranted.

Keyphrases

type diabetes
minimally invasive
coronary artery bypass
glycemic control
surgical site infection
coronary artery disease
insulin resistance
weight loss
skeletal muscle